Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
HeartBeam, Inc.

HeartBeam, Inc. (BEAT) Stock Overview

Explore HeartBeam, Inc.’s financial performance, market position, analyst ratings, and future outlook.

BEAT●NASDAQ
HealthcareMedical - Equipment & Services
$0.49
$0.02(3.14%)
U.S. Market opens in 62h 58m

HeartBeam, Inc. (BEAT)

Meyka AI Score

Z

Key Financials

Market Cap27.4M
P/E Ratio-0.93
EPS (TTM)$-0.51
ROE-6.87%
Fundamental Analysis

AI Price Forecasts

1 Month$1.06
3 Months$0.91
1 Year Target$1.88

BEAT Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of HeartBeam, Inc. (NASDAQ: BEAT) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, HeartBeam, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of BEAT on the NASDAQ shows an RSI of 38.93, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $1.88 for the NASDAQ listing.

Key metrics behind HeartBeam, Inc.'s NASDAQ-traded stock include a P/E ratio of -0.93 and a market capitalization of 27.4M. Combined with our AI analysis, these give both institutional and retail investors a clear view of BEAT on the NASDAQ.

Price Performance (NASDAQ: BEAT)

1-Day Change
3.14%
5-Day Change
-11.91%
1-Month Change
-16.70%
3-Month Change
-46.41%
6-Month Change
-65.01%
Year-to-Date (YTD) Change
-79.45%
1-Year Change
-54.32%
3-Year Change
-77.98%
5-Year Change
-89.48%
All-Time (Max) Change
-89.48%

Contact Information

https://www.heartbeam.com
408 899 4443
2118 Walsh Avenue, Santa Clara, CA, 95050

Company Facts

170 Employees
IPO DateNov 16, 2021
CountryUS
Actively Trading

Frequently Asked Questions